DCF Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,500
| Closed | -$986K | – | 85 |
|
|
2023
Q3 | $986K | Buy |
+13,500
| New | +$986K | 0.54% | 35 |
|
|
2023
Q1 | – | Sell |
-3,500
| Closed | -$291K | – | 74 |
|
|
2022
Q4 | $291K | Buy |
+3,500
| New | +$291K | 0.2% | 49 |
|
|
2022
Q3 | – | Sell |
-10,000
| Closed | -$743K | – | 76 |
|
|
2022
Q2 | $743K | Buy |
+10,000
| New | +$743K | 0.44% | 39 |
|